StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com

Scilex Holding Gets Nasdaq Notice Over $35 Million Market Value Rule

Scilex Holding said Nasdaq notified it on Nov. 17, 2026 that its listed securities' market value fell below the $35 million minimum for 30 straight business days; shares fell 13%.

What happened

Scilex Holding Company (Nasdaq: SCLX), a Palo Alto, California-based company that develops and sells non-opioid pain treatments, disclosed in an 8-K filed Nov. 20, 2026 that Nasdaq's Listing Qualifications Department notified it on Nov. 17 that the market value of its listed securities had been below the $35 million minimum for 30 consecutive business days, from Oct. 6 through Nov. 16, 2026.

The notice also said the company does not meet the alternative continued listing standards under Nasdaq rules 5550(b)(1) and 5550(b)(3), which relate to minimum stockholders' equity and net income from continuing operations.

Scilex shares closed at $0.5658 on the event date, down 12.95% from the prior close of $0.65, according to the price data.

The company said the notice has no immediate effect on the listing or trading of its common stock (SCLX) or its publicly traded warrants (SCLXW), which continue to trade on the Nasdaq Capital Market. The company said it intends to monitor its market value and is evaluating options to regain compliance, but said there can be no assurance it will do so in time.

What Nasdaq requires

The rule at issue, Nasdaq Listing Rule 5550(b)(2), is one of three ways a company can satisfy the Nasdaq Capital Market's continued listing standards. A company must generally meet one of them: a minimum market value of listed securities, a minimum level of stockholders' equity, or a minimum amount of net income from continuing operations. Scilex's filing says it fails all three.

Market value of listed securities is calculated by multiplying the share price by the number of shares outstanding, and the same for other listed classes. It is a measure of total market worth, not of the share price itself, so a company can fall below the threshold either because its stock price falls or because its share count falls.

Nasdaq Listing Rule 5810(c)(3)(C) gives the company 180 calendar days, or until May 17, 2027, to regain compliance. If the market value closes at $35 million or more for at least ten consecutive business days before that date, Nasdaq will confirm compliance in writing and close the matter. Nasdaq may in its discretion require a longer stretch, generally no more than 20 consecutive business days.

If the company has not regained compliance by May 17, 2027, Nasdaq will notify it that its securities are subject to delisting. At that point the company can appeal to a Nasdaq Hearings Panel.

What this means

An 8-K is a current report that a public company files with the SEC when a significant event occurs between quarterly reports. Item 3.01 of the form is specifically for notice of a delisting or a failure to meet a continued listing rule. The 8-K does not by itself remove Scilex from Nasdaq; it records that the exchange has flagged a shortfall and started a cure period.

The distinction matters for readers who see the word delisting. A delisting notice at this stage is a warning with a deadline, not a removal. Scilex's securities keep trading under SCLX and SCLXW throughout the compliance period unless something else happens.

The warrants listed alongside the stock are separate securities that give the holder the right to buy one share at a fixed price. Scilex's warrants carry an exercise price of $397.89 per share, a figure set far above the current share price, which means exercising them today would cost vastly more than buying the stock in the market. The filing does not explain why the exercise price is set at that level.

The filing does not say why the company's market value fell below the threshold, beyond the 30-day measurement period. It also does not describe which specific options the company is considering to regain compliance.

Sources

Information summarized by AI from the sources listed above. May contain errors — informational only, not investment advice.